Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997, 90 (12): 5002-5012.
CAS
PubMed
Google Scholar
Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. 1997, 90 (12): 5013-5021.
CAS
PubMed
Google Scholar
Weigmann A, Corbeil D, Hellwig A, Huttner WB: Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA. 1997, 94 (23): 12425-12430. 10.1073/pnas.94.23.12425.
Article
CAS
PubMed
PubMed Central
Google Scholar
Corbeil D, Roper K, Hellwig A, Tavian M, Miraglia S, Watt SM, Simmons PJ, Peault B, Buck DW, Huttner WB: The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem. 2000, 275 (8): 5512-5520. 10.1074/jbc.275.8.5512.
Article
CAS
PubMed
Google Scholar
Corbeil D, Roper K, Fargeas CA, Joester A, Huttner WB: Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic. 2001, 2 (2): 82-91. 10.1034/j.1600-0854.2001.020202.x.
Article
CAS
PubMed
Google Scholar
Mizrak D, Brittan M, Alison MR: CD133: molecule of the moment. J Pathol. 2008, 214 (1): 3-9. 10.1002/path.2283.
Article
CAS
PubMed
Google Scholar
Burkert J, Wright NA, Alison MR: Stem cells and cancer: an intimate relationship. J Pathol. 2006, 209 (3): 287-297. 10.1002/path.2016.
Article
CAS
PubMed
Google Scholar
Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature. 2007, 445 (7123): 111-115. 10.1038/nature05384.
Article
CAS
PubMed
Google Scholar
Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP, et al: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell. 2007, 1 (4): 389-402. 10.1016/j.stem.2007.08.001.
Article
CAS
PubMed
Google Scholar
Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65 (23): 10946-10951. 10.1158/0008-5472.CAN-05-2018.
Article
CAS
PubMed
Google Scholar
Kasper S: Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev. 2008, 4 (3): 193-201. 10.1007/s12015-008-9033-1.
Article
CAS
PubMed
Google Scholar
Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007, 1 (3): 313-323. 10.1016/j.stem.2007.06.002.
Article
CAS
PubMed
Google Scholar
Bruno S, Bussolati B, Grange C, Collino F, Graziano ME, Ferrando U, Camussi G: CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol. 2006, 169 (6): 2223-2235. 10.2353/ajpath.2006.060498.
Article
CAS
PubMed
PubMed Central
Google Scholar
Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL: Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA. 2000, 97 (26): 14720-14725. 10.1073/pnas.97.26.14720.
Article
CAS
PubMed
PubMed Central
Google Scholar
Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63 (18): 5821-5828.
CAS
PubMed
Google Scholar
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature. 2004, 432 (7015): 396-401. 10.1038/nature03128.
Article
CAS
PubMed
Google Scholar
Beier D, Wischhusen J, Dietmaier W, Hau P, Proescholdt M, Brawanski A, Bogdahn U, Beier CP: CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol. 2008, 18 (3): 370-377. 10.1111/j.1750-3639.2008.00130.x.
Article
PubMed
Google Scholar
Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H: Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun. 2006, 351 (4): 820-824. 10.1016/j.bbrc.2006.10.128.
Article
CAS
PubMed
Google Scholar
Yin S, Li J, Hu C, Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D, et al: CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer. 2007, 120 (7): 1444-1450. 10.1002/ijc.22476.
Article
CAS
PubMed
Google Scholar
Immervoll H, Hoem D, Sakariassen PO, Steffensen OJ, Molven A: Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer. 2008, 8: 48-10.1186/1471-2407-8-48.
Article
PubMed
PubMed Central
Google Scholar
Horst D, Kriegl L, Engel J, Kirchner T, Jung A: CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer. 2008
Google Scholar
Song W, Li H, Tao K, Li R, Song Z, Zhao Q, Zhang F, Dou K: Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int J Clin Pract. 2008, 62 (8): 1212-1218. 10.1111/j.1742-1241.2008.01777.x.
Article
CAS
PubMed
Google Scholar
Shimada M, Sugimoto K, Iwahashi S, Utsunomiya T, Morine Y, Imura S, Ikemoto T: CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol. 2010, 45 (8): 896-902. 10.1007/s00535-010-0235-3.
Article
CAS
PubMed
Google Scholar
Nakanuma YSB, Vatanasapt V, Leong AS-Y, Ponchon T, Ishak KG: Intrahepatic cholangiocarcinoma. World Health Organization classification of tumours Pathology and genetics of tumours of the digestive system. Edited by: Hamilton SR AL. 2000, Lyon: France:IARC Press, 173-180.
Google Scholar
Kojima M, Ishii G, Atsumi N, Fujii S, Saito N, Ochiai A: Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study. Cancer Sci. 2008, 99 (8): 1578-1583. 10.1111/j.1349-7006.2008.00849.x.
Article
CAS
PubMed
Google Scholar
Lyman Ott ML: An introduction to statistical methods and data analysis. 2008, Belmont: Cengage Learning, 6
Google Scholar
Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB, Corbeil D: Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res. 2005, 319 (1): 15-26. 10.1007/s00441-004-1018-z.
Article
CAS
PubMed
Google Scholar
Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, et al: CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest. 2008, 118 (6): 2111-2120.
CAS
PubMed
PubMed Central
Google Scholar
Marzesco AM, Janich P, Wilsch-Brauninger M, Dubreuil V, Langenfeld K, Corbeil D, Huttner WB: Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci. 2005, 118 (Pt 13): 2849-2858.
Article
CAS
PubMed
Google Scholar
Jaszai J, Janich P, Farkas LM, Fargeas CA, Huttner WB, Corbeil D: Differential expression of Prominin-1 (CD133) and Prominin-2 in major cephalic exocrine glands of adult mice. Histochem Cell Biol. 2007, 128 (5): 409-419. 10.1007/s00418-007-0334-2.
Article
CAS
PubMed
Google Scholar
Jaszai J, Fargeas CA, Florek M, Huttner WB, Corbeil D: Focus on molecules: prominin-1 (CD133). Exp Eye Res. 2007, 85 (5): 585-586. 10.1016/j.exer.2006.03.022.
Article
CAS
PubMed
Google Scholar
Sapkota GP, Cummings L, Newell FS, Armstrong C, Bain J, Frodin M, Grauert M, Hoffmann M, Schnapp G, Steegmaier M, et al: BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem J. 2007, 401 (1): 29-38. 10.1042/BJ20061088.
Article
CAS
PubMed
Google Scholar
Karbanova J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P, Hollerova H, Jaszai J, Ehrmann J, Kolar Z, Liebers C, et al: The Stem Cell Marker CD133 (Prominin-1) is Expressed in Various Human Glandular Epithelia. J Histochem Cytochem. 2008
Google Scholar
Bidlingmaier S, Zhu X, Liu B: The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med. 2008, 86 (9): 1025-1032. 10.1007/s00109-008-0357-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC: Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res. 2008, 14 (1): 123-129. 10.1158/1078-0432.CCR-07-0932.
Article
CAS
PubMed
Google Scholar
Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M, Natsugoe S, Aikou T, Takao S: CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer. 2008, 98 (8): 1389-1397. 10.1038/sj.bjc.6604307.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fargeas CA, Joester A, Missol-Kolka E, Hellwig A, Huttner WB, Corbeil D: Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci. 2004, 117 (Pt 18): 4301-4311.
Article
CAS
PubMed
Google Scholar
Shmelkov SV, Jun L, St Clair R, McGarrigle D, Derderian CA, Usenko JK, Costa C, Zhang F, Guo X, Rafii S: Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood. 2004, 103 (6): 2055-2061. 10.1182/blood-2003-06-1881.
Article
CAS
PubMed
Google Scholar